Drugs for Migraine Treatment and Prophylaxis Flashcards
Acetaminophen and NSAIDS
DRUGS FOR ACUTE MILD TO MODERATE ATTACKS
ACETAMINOPHEN & NSAIDs
For mild to moderate attacks not associated with vomiting or severe nausea, acetaminophen and NSAIDs are first choice.
Triptans
DRUGS FOR ACUTE MODERATE TO SEVERE ATTACKS
TRIPTANS
Sumatriptan
Triptans are the drug of choice for treatment of moderate-to-severe migraine.
Triptans are selective agonists at 5-HT1D and 5-HT1B receptors. Combination of sumatriptan and naproxen provides better pain relief than either agent taken alone.
Subcutaneous sumatriptan is the fastest-acting and most effective triptan formulation.
ADVERSE EFFECTS
Tingling, flushing, dizziness, drowsiness, fatigue, and a feeling of heaviness, tightness, or pressure in the chest. Angina, myocardial infarction, cardiac arrhythmia, stroke, and death have occurred rarely with triptans.
Triptans are contraindicated in patients with coronary, cerebrovascular or other arterial disease, or uncontrolled hypertension.
Triptans should be used with caution in patients with other risk factors for vascular disease, particularly diabetes.
Ergot Alkaloids
DRUGS FOR ACUTE MODERATE TO SEVERE ATTACKS
ERGOT ALKALOIDS
Ergotamine, Dihydroergotamine
Ergotamine acts as an agonist at α-adrenoceptors, 5-HT receptors (particularly 5- HT1B/1D) and dopamine D2 receptors
Based on the mechanism of action of the triptans, the agonist actions of ergot alkaloids at 5-HT1B/1D receptors likely mediate their acute anti-migraine effects.
ADVERSE EFFECTS
Nausea and vomiting are fairly common with ergotamine, but can be prevented by pretreatment with or concurrent use of an antiemetic such as metoclopramide.
Serious adverse effects, such as vascular (including coronary) occlusion and gangrene, are rare and are usually associated with overdosage. Liver disease or fever can accelerate development of severe vasoconstriction.
Dihydroergotamine is a weaker vasoconstrictor than ergotamine and causes fewer adverse effects.
Ergots are contraindicated in patients with arterial disease or uncontrolled hypertension.
DRUGS FOR PREVENTION OF MIGRAINE
Patients with frequent or severe disabling migraine headaches should receive prophylactic treatment.
The mechanisms of action of drugs used for migraine prophylaxis are diverse; no single drug has emerged as a clear treatment of choice.
B-Blockers
FIRST LINE AGENTS: BETA BLOCKERS
Propranolol Timolol Metoprolol Nadolol Atenolol
For continuous prophylaxis, beta blockers are commonly used. Up to 80% of patients achieve complete or partial response.
Valproate
FIRST LINE AGENTS: ANTIEPILEPTICS
Valproate
Valproate is indicated for the treatment of manic episodes associated with bipolar disorder, epileptic seizures, and prophylaxis of migraine headache.
Valproate inhibits voltage gated Na+ channels and T-type Ca2+ channels.
Adverse effects: GI side effects. Thrombocytopenia. Rarely hepatotoxicity. Teratogenic.
Topiramate
FIRST LINE AGENTS: ANTIEPILEPTICS
Topiramate
Topiramate is indicated for the treatment of epileptic seizures and prophylaxis of migraine headache.
Topiramate inhibits voltage-gated Na+ channels. Additionally, it is a GABAA receptor agonist and an antagonist at glutamate receptors.
Adverse effects: Somnolence, fatigue, dizziness, cognitive slowing, nervousness, and confusion. Acute myopia, glaucoma. Hyperthermia, renal stones. Teratogenic.
Amitriptyline
TRICYCLIC ANTIDEPRESSANTS
Nortriptyline
TRICYCLIC ANTIDEPRESSANTS
Imipramine
TRICYCLIC ANTIDEPRESSANTS
TRICYCLIC ANTIDEPRESSANTS
TRICYCLIC ANTIDEPRESSANTS
Amitriptyline Nortriptyline Imipramine
TCAs can be used in combination with propranolol to increase efficacy and decrease adverse effects. Clomipramine is not effective.
TCAs inhibit norepinephrine and serotonin reuptake.
Adverse effects: Sedation, dry mouth, weight gain.
Venlafaxine
SEROTONIN & NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs)
Venlafaxine
Adverse effects: nausea, constipation, insomnia, headaches, sexual dysfunction.
Verapamil
CALCIUM CHANNEL BLOCKERS
Verapamil
Calcium channel blockers are used for prevention of migraine, but evidence for their effectiveness is weak. Verapamil is the CCB with most evidence of efficacy.
Gabapentin
ANTIEPILEPTICS
Gabapentin
Gabapentin decreases glutamate release; this effect is a consequence of blockade of presynaptic voltage-gated Ca2+ channels.
Adverse effects: sleepiness, dizziness, fatigue
Lisinopril and Candesartan
ACEIs & ARBs
Lisinopril and candesartan have reduced migraine frequency by about 30%.